Tag: SCANDV
Eisai, Biogen receives U.S. FDA approval for Alzheimer's drug, applies for full approval
The drug aims to slow the advance of the neurodegenerative disease. Nearly all previous experimental drugs using the same approach have failed.
0
0
0
7 Jan, 07:19 AM
